Cargando…
Global incidence and prevalence of nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) is a leading cause of liver disease worldwide. The estimated global incidence of NAFLD is 47 cases per 1,000 population and is higher among males than females. The estimated global prevalence of NAFLD among adults is 32% and is higher among males (40%) compar...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association for the Study of the Liver
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029957/ https://www.ncbi.nlm.nih.gov/pubmed/36517002 http://dx.doi.org/10.3350/cmh.2022.0365 |
_version_ | 1784910252262555648 |
---|---|
author | Teng, Margaret LP Ng, Cheng Han Huang, Daniel Q. Chan, Kai En Tan, Darren JH Lim, Wen Hui Yang, Ju Dong Tan, Eunice Muthiah, Mark D. |
author_facet | Teng, Margaret LP Ng, Cheng Han Huang, Daniel Q. Chan, Kai En Tan, Darren JH Lim, Wen Hui Yang, Ju Dong Tan, Eunice Muthiah, Mark D. |
author_sort | Teng, Margaret LP |
collection | PubMed |
description | Nonalcoholic fatty liver disease (NAFLD) is a leading cause of liver disease worldwide. The estimated global incidence of NAFLD is 47 cases per 1,000 population and is higher among males than females. The estimated global prevalence of NAFLD among adults is 32% and is higher among males (40%) compared to females (26%). The global prevalence of NAFLD has increased over time, from 26% in studies from 2005 or earlier to 38% in studies from 2016 or beyond. The prevalence of NAFLD varies substantially by world region, contributed by differing rates of obesity, and genetic and socioeconomic factors. The prevalence of NAFLD exceeds 40% in the Americas and South-East Asia. The prevalence of NAFLD is projected to increase significantly in multiple world regions by 2030 if current trends are left unchecked. In this review, we discuss trends in the global incidence and prevalence of NAFLD and discuss future projections. |
format | Online Article Text |
id | pubmed-10029957 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | The Korean Association for the Study of the Liver |
record_format | MEDLINE/PubMed |
spelling | pubmed-100299572023-03-22 Global incidence and prevalence of nonalcoholic fatty liver disease Teng, Margaret LP Ng, Cheng Han Huang, Daniel Q. Chan, Kai En Tan, Darren JH Lim, Wen Hui Yang, Ju Dong Tan, Eunice Muthiah, Mark D. Clin Mol Hepatol Review Nonalcoholic fatty liver disease (NAFLD) is a leading cause of liver disease worldwide. The estimated global incidence of NAFLD is 47 cases per 1,000 population and is higher among males than females. The estimated global prevalence of NAFLD among adults is 32% and is higher among males (40%) compared to females (26%). The global prevalence of NAFLD has increased over time, from 26% in studies from 2005 or earlier to 38% in studies from 2016 or beyond. The prevalence of NAFLD varies substantially by world region, contributed by differing rates of obesity, and genetic and socioeconomic factors. The prevalence of NAFLD exceeds 40% in the Americas and South-East Asia. The prevalence of NAFLD is projected to increase significantly in multiple world regions by 2030 if current trends are left unchecked. In this review, we discuss trends in the global incidence and prevalence of NAFLD and discuss future projections. The Korean Association for the Study of the Liver 2023-02 2022-12-14 /pmc/articles/PMC10029957/ /pubmed/36517002 http://dx.doi.org/10.3350/cmh.2022.0365 Text en Copyright © 2023 by The Korean Association for the Study of the Liver https://creativecommons.org/licenses/by-nc/3.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Teng, Margaret LP Ng, Cheng Han Huang, Daniel Q. Chan, Kai En Tan, Darren JH Lim, Wen Hui Yang, Ju Dong Tan, Eunice Muthiah, Mark D. Global incidence and prevalence of nonalcoholic fatty liver disease |
title | Global incidence and prevalence of nonalcoholic fatty liver disease |
title_full | Global incidence and prevalence of nonalcoholic fatty liver disease |
title_fullStr | Global incidence and prevalence of nonalcoholic fatty liver disease |
title_full_unstemmed | Global incidence and prevalence of nonalcoholic fatty liver disease |
title_short | Global incidence and prevalence of nonalcoholic fatty liver disease |
title_sort | global incidence and prevalence of nonalcoholic fatty liver disease |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029957/ https://www.ncbi.nlm.nih.gov/pubmed/36517002 http://dx.doi.org/10.3350/cmh.2022.0365 |
work_keys_str_mv | AT tengmargaretlp globalincidenceandprevalenceofnonalcoholicfattyliverdisease AT ngchenghan globalincidenceandprevalenceofnonalcoholicfattyliverdisease AT huangdanielq globalincidenceandprevalenceofnonalcoholicfattyliverdisease AT chankaien globalincidenceandprevalenceofnonalcoholicfattyliverdisease AT tandarrenjh globalincidenceandprevalenceofnonalcoholicfattyliverdisease AT limwenhui globalincidenceandprevalenceofnonalcoholicfattyliverdisease AT yangjudong globalincidenceandprevalenceofnonalcoholicfattyliverdisease AT taneunice globalincidenceandprevalenceofnonalcoholicfattyliverdisease AT muthiahmarkd globalincidenceandprevalenceofnonalcoholicfattyliverdisease |